Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 May 2022 07:00

RNS Number : 3481M
DeepMatter Group PLC
23 May 2022
 

23 May 2022

 

Alan Aubrey appointed Chairman of DeepMatter

 

DeepMatter Group Plc (AIM: DMTR, "Deepmatter", the "Group"), the digital chemistry data and software company, announces the appointment of Alan Aubrey as non-executive Chairman after the AGM on the 27 May 2022. He takes over from Karen Bach, who is retiring from the board and leaving the Group.

 

Alan has a successful 20-year track record in founding, developing, and growing disruptive technology businesses. He co-founded Techtran Limited in 2002, which was acquired in 2005 by IP Group Plc, a company that develops world-changing science and technology businesses across life sciences, technology and cleantech. Alan was appointed IP Group's CEO shortly after the acquisition and he went on to lead the business to become a member of the FTSE 250.

 

Alan brings significant experience to the Group in the commercialisation of science and the creation of high growth technology businesses that address global markets. Amongst other businesses, Alan has served on the boards of high-profile technology businesses such as Oxford Nanopore Technologies plc and Ceres Power Holdings Plc. He contributed to the growth of dozens of businesses in the life sciences, manufacturing and sustainability industries.

 

Alan is currently non-executive chairman of OxCCU Limited, an Oxford University spin-out focused using CO₂ and renewable energy to make sustainable fuels, chemicals and plastics. He also is a director of both Trellix Limited and Rio AI Limited, which are applying Artificial Intelligence to address business problems.

 

Alan is a Chartered Accountant and from 1995-2001, was a corporate finance partner in KPMG. 

 

Alan is subscribing for 200,000,000 new ordinary shares in the Group at a price of 0.1p per share, prior to his starting date. A further announcement in relation to the subscription will be issued in due course.

Alan currently holds 7,311,393 ordinary shares representing 0.19 per cent of the total voting rights in the Company.

Mark Warne, Chief Executive of DeepMatter, said:

 

"On behalf of everyone at Deepmatter, I would like to thank Karen for her valued contribution and support over the last 20 months which sees the business well positioned for the market opportunity ahead of it. We are delighted that Alan will join us as we enter the next phase of growth."

 

Karen Bach, Chair of Deepmatter said:

 

"Over the past 20 months the Group has built a great team and established the building blocks to commercialise both data and technology. I am proud of the progress we made in this early commercialisation phase. The business has an exciting delivery phase ahead and I wish the team well."

 

Alan Aubrey, Chairman-designate of DeepMatter, commented:

 

"I am joining Deepmatter at a very exciting and dynamic time. Chemistry touches all our lives but the research and development of new chemical formulae remains relatively unsophisticated.

 

"Our vision is to build the capabilities for scientists to access and exploit vast amounts of chemical reaction data. Our SmartChemistry™ platform provides easy access and exploitation of the data in order to make chemical reaction discovery and design faster, safer, more efficient and increasingly sustainable. The recently announced multi-year SmartChemistry™ contracts with Standigm and Springer Nature are evidence of this."

 

For more information contact

 

DeepMatter Group Plc Fraser Benson, Chief Financial Officer 0141 548 8156

Canaccord Genuity Limited (Nominated Advisor and Broker) 020 7523 8000Bobbie Hilliam

Meare Consulting 07990 858548Adrian Duffield

About DeepMatter Group plc 

 

DeepMatter's SmartChemistry™ platform enables scientists across a range of industries, including pharma, biotech, agri-science, scientific publishers and contract research organisations (CROs), to easily capture, access and exploit the vast amounts of data created in chemical reactions.

 

DeepMatter integrates its proprietary chemistry data and proprietary software to significantly improve productivity, efficiency, discovery, safety and sustainability of chemical reactions for its customers.

 

DeepMatter's SmartChemistry™ platform capitalises on the combination of its cloud technology, low cost-sensors, connectivity to laboratory hardware and high-performance computing trends such as artificial intelligence (AI).

 

Visit: www.deepmatter.io and follow @deepmattergroup

 

 

As required under Schedule Two, paragraph (g) of the AIM Rules for Companies, further disclosures on Mr Aubrey are as follows:

 

Mr Alan John Aubrey, aged 61, has held the following directorships and/or partnerships in the past five years:

 

Current directorships and/or partnerships:

IP2IPO Services Limited

Rio Al Limited

Trellix Limited

EUREKA! THE NATIONAL CHILDREN'S MUSEUM

Redcentric plc (effective 22 July 2022)

 

 

 

Past directorships and/or partnerships:

· Top Technology Ventures Limited

· IP Assist Services Limited

· IP2IPO Asia-Pacific Limited

· IP2IPO Innovations Limited

· IP2IPO Limited

· LifeUK (IP2IPO) Limited

· IP Ventures (Scotland) Limited

· IP Industry Partners Limited

· IP2IPO ANZ Carry Limited

· Avacta Group Plc

· IP Group Plc

· MOBILIOn Inc

· Oxford Nanopore Technologies Plc

· IP2IPO Guarantee Limited

· Oxford Science Enterprises Plc

· IP2IPO Management VI Limited

· Proactis Holdings Plc

· IP2IPO Management V Limited

· Ceres Power Intermediate Holdings Limited

· IP2IPO (Europe) Limited

· Ceres Power Holdings Plc

· IP2IPO Management IV Limited

· North East Technology (GP) Limited

· IP Venture Fund (GP) Limited

· Touchstone Innovations Limited

· IP2IPO Management II Limited

· IP2IPO Company Maker Limited

· IP2IPO Management Limited

· IP2IPO US Partners Limited

· Innovations Limited Partner Ltd

· IP2IPO Americas Limited

· Touchstone Innovations Investments Limited

 

There is no further information on Mr Aubrey required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUPWAUPPGBP
Date   Source Headline
5th Jan 20237:00 amRNSCancellation - DEEPMATTER GROUP PLC
4th Jan 20238:00 amRNSHolding(s) in Company
29th Dec 20225:30 pmRNSDeepmatter Group
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20223:44 pmRNSResult of General Meeting
19th Dec 20222:05 pmRNSSecond Price Monitoring Extn
19th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 202211:05 amRNSSecond Price Monitoring Extn
19th Dec 202211:00 amRNSPrice Monitoring Extension
15th Dec 20224:40 pmRNSSecond Price Monitoring Extn
15th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20222:05 pmRNSSecond Price Monitoring Extn
15th Dec 20222:00 pmRNSPrice Monitoring Extension
9th Dec 202211:05 amRNSSecond Price Monitoring Extn
9th Dec 202211:00 amRNSPrice Monitoring Extension
8th Dec 20228:46 amRNSHolding(s) in Company
2nd Dec 20227:00 amRNSPosting of Circular
1st Dec 20227:00 amRNSProposed Cancellation of Ordinary Shares
24th Nov 20227:00 amRNSCorporate Update
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSTrading Update
26th Oct 20227:00 amRNSDeepMatter signs multi-year license agreement
26th Aug 20221:25 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHalf Year Results
28th Jun 20227:00 amRNSDeepMatter acquires AI specialist ChemIntelligence
20th Jun 20224:41 pmRNSSecond Price Monitoring Extn
20th Jun 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20222:05 pmRNSSecond Price Monitoring Extn
20th Jun 20222:00 pmRNSPrice Monitoring Extension
20th Jun 202211:05 amRNSSecond Price Monitoring Extn
20th Jun 202211:00 amRNSPrice Monitoring Extension
9th Jun 20225:26 pmRNSHolding(s) in Company
27th May 20222:30 pmRNSResult of AGM
25th May 20222:30 pmRNSIssue of Equity and TVR
23rd May 20227:00 amRNSDirectorate Change
20th May 20227:00 amRNSContract extension
11th May 20227:00 amRNSContract
27th Apr 20227:00 amRNSFinal Results
30th Mar 20224:00 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSContract
14th Feb 20227:00 amRNSDirector/PDMR Shareholding
26th Jan 20223:20 pmRNSHolding(s) in Company
26th Jan 20223:15 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSHolding(s) in Company
25th Jan 20225:45 pmRNSHolding(s) in Company
25th Jan 202212:30 pmRNSHolding(s) in Company
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.